(PharmaNewsWire.Com, March 16, 2018 ) The report "Middle East and Africa Pharmaceutical Contract Manufacturing Market”: By Type, By Product, By Technology & By Geography - Trends & Forecast (2018-2024). Envision Inteligence estimates that Global Pharmaceutical Contract Manufacturing Market is projected to reach $94.40 Billion by the end of 2024 with a CAGR of 6.40% from $65.12 Billion in 2017.
Introduction: Contract manufacturing is an outsourcing of certain production activities that were previously performed by the manufacturer to a third party. A company may outsource the manufacture of certain components for the product or outsource the assembly of the product.
Injectable dose formulation to grow on an account of high demand by 2024. Injectable dose formulation is the fastest growing segment with a projected rate of 12.2% which is higher than the overall pharmaceutical contract manufacturing market. The growth of the Injectable dose formulation segment is due to the increased focus on cytotoxics, lyophilised prefilled syringes and reformulation of existing products. The liquid and semi-solid dose formulation segment is declining because of the storage and transportation issues and solid dose formulations is the largest segment owing to the primarily attributed to lower cost, ease of manufacturing, patient compliance and the patent cliff.
Key players in the market include: • Recipharm AB • Catalent, Inc. • Patheon Inc. • Jubliant life sciences Ltd • Boehringer Ingelheim
Reasons to buy this report: This report contains the in-depth analysis on the market and the estimations are done using volume and value data are further validated on three approaches including bottom-up, top-down and from top companies revenues to conclude the market estimations precisely and accurately considering all the parameters and market dynamics.
Key pointers in the report include: • Competitive landscape & market analysis is included in the report to understand the key companies’ position and Porter's Analysis, PESTLE analysis, SWOT Analysis& Y-O-Y analysisare performed to comprehend the market dynamics and key companies’ position during the next five years. • Team of analysts have analyzed and listed out the key drivers, constraints, challenges and emerging opportunities in all the industry verticals, which will specify the emerging scope for the market in end user industries. • Industry value chain analysis is provided in the report to identify the key stakeholders and prominent players at each stage of the company along with the value addition at each stage of the value chain. • Complete analysis including global and regional trends, technological developments, and new product innovations are included in the report specific to each segment of the market. • A complete 360 degree analysis including product portfolio, business portfolio, developmental strategies, key developments from the companies in the historical period for the key players operating in the market is included in the report. • Advanced customizations on countries, specific applications in end user industries, product based customizations will be provided based on the request. All the collected data is further validated and verified using surveys, interviews and interactions with industrial experts.
Envision Inteligence is the main supplier of market analysis reviews, customized consulting, information analytics and trade evaluation. Our purpose is to offer the accurate and precise data required by the stakeholder on the proper level of time, in a format, which assists in making the optimized business decisions, and to stay ahead among all the competitors in the associated markets.
Contact Us Envision Inteligence Sales Team: Mail ID: Sales@envisioninteligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
